Download this free whitepaper to learn how Clinical Ink’s ePRO technology, Engage, brings a timely, easy-to-implement, cost-effective solution to Phase 1 studies.
This free whitepaper will demonstrate how Clinical Ink’s ePRO technology, Engage, can solve long-standing issues with paper-based Phase I clinical trials, including the lack of data attributability, the inability to monitor patient activity in real-time and the time it takes to transcribe subject reported data into an ECF.
Read this whitepaper to learn how Engage revolutionizes Phase I trials with:
Clinical Ink’s eSource platform supports the full range of validated ePRO questionnaires and eCOA-based CliniROs, ObsROs, PerfOs and Structured Diagnostic Interviews for both site- and home-based settings. The platform provides complete support for protocol requirements, offers regularly scheduled data transfers and has been deployed for use in all phases of clinical trials and across a wide range of therapeutic areas. Clinical Ink University also provides full-service training by web or at your site
Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. By connecting clients to a proven and future-built eSource platform that accelerates time to value while delivering scientific results that matter, we’re proud to be advancing the business model responsible for bringing new treatments to market.